Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Commodities

European Steel Giant Faces Existential Threat from Subsidized Imports

Robert Sasse by Robert Sasse
September 3, 2025
in Commodities, European Markets, Industrial, Turnaround
0
Thyssenkrupp Stock
0
SHARES
243
VIEWS
Share on FacebookShare on Twitter

Thyssenkrupp, one of Europe’s industrial pillars, is confronting a severe survival challenge as heavily subsidized Chinese steel floods the market. Dennis Grimm, a senior executive at Thyssenkrupp Steel Europe, has issued a stark warning about the potentially devastating impact on the company’s core operations and the broader European steel industry.

Unfair Competition Undermining Market Stability

The European steel sector is grappling with a massive structural imbalance. Chinese competitors, benefiting from significant state subsidies, are exporting steel at prices up to 50% lower than European producers can match. This has created a market environment where approximately 700 million tons of global excess capacity are suppressing prices and threatening the viability of established producers.

For Thyssenkrupp, this translates directly into lost contracts as customers increasingly turn to cheaper alternatives. The company’s steel division, traditionally the operational backbone of the conglomerate, is experiencing substantial order erosion that jeopardizes its fundamental business model.

Grimm emphasized that the consequences extend beyond simple price competition. Critical transformation initiatives are being delayed, blast furnace operations are coming under intense pressure, and the entire industrial value chain is showing signs of fragmentation.

Policy Intervention Becomes Critical

In response to this escalating crisis, Thyssenkrupp’s leadership has outlined specific measures they believe policymakers must implement urgently:

Should investors sell immediately? Or is it worth buying Thyssenkrupp?

  • Immediate trade protections: Swift action against subsidized imports that distort market pricing
  • Comprehensive CBAM implementation: A Carbon Border Adjustment Mechanism without exemptions or loopholes
  • Domestic content requirements: Binding quotas for European-produced materials in public procurement projects

Company management stresses that without rapid deployment of proposed import tariffs and quota reductions, the European steel industry could sustain permanent damage.

Naval Division Suffers Significant Setback

Compounding the steel sector difficulties, Thyssenkrupp’s marine systems subsidiary (TKMS) has encountered a major setback. The division, considered a strategic growth pillar, recently lost a multibillion-euro contract with Norway for new frigate construction to British competition.

The NATO member’s decision to award the contract to a non-German company represents a substantial blow to TKMS, which had been viewed as a promising component of the conglomerate’s diversification strategy.

Despite these mounting challenges, Thyssenkrupp shares have demonstrated remarkable resilience, posting an impressive 188% annual gain. However, analysts caution that without effective political intervention to level the playing field against unfairly subsidized competition, this market performance may prove unsustainable.

Ad

Thyssenkrupp Stock: Buy or Sell?! New Thyssenkrupp Analysis from February 7 delivers the answer:

The latest Thyssenkrupp figures speak for themselves: Urgent action needed for Thyssenkrupp investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Thyssenkrupp: Buy or sell? Read more here...

Tags: Thyssenkrupp
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Schnitzer Steel Industries Stock
Analysis

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

February 6, 2026
Xiaobai Maimai Stock
Asian Markets

Akso Health Group Pivots to Oncology with Global Patient Initiative

February 6, 2026
Next Post
Almonty Stock

Almonty Shares Under Pressure Following Steep Quarterly Loss

Rheinmetall Stock

Rheinmetall's Strategic Expansion into Naval and Space Defense Markets

Independent Bank Stock

Independent Bank Capitalizes on Strong Performance with Strategic Investor Outreach

Recommended

Jakks Pacific Reports Disappointing Q4 2023 Earnings

2 years ago
Ecommerce Stock Exchange

Notable Options Market Activity for Shopify

2 years ago
Fannie Mae Stock

Fannie Mae’s Public Offering Plans Derailed by Prominent Investor

3 months ago
Ocugen Stock

Ocugen Shares Face Critical Test Amid Steep Decline

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Trending

Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

by Rodolfo Hanigan
February 7, 2026
0

Investors in Viking Therapeutics are currently focused on a specific calendar event rather than breaking news. The...

Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026
Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment
  • Diginex Enters Critical Implementation Phase Following Strategic Moves
  • Deluxe Stock Gains Momentum on Successful Fintech Transition

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com